{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T04:51:40Z","timestamp":1767761500577,"version":"3.48.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.heliyon.2021.e07740","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T13:34:38Z","timestamp":1628516078000},"page":"e07740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation"],"prefix":"10.1016","volume":"7","author":[{"given":"Luis M.","family":"Carbajal-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-9435","authenticated-orcid":false,"given":"Mart\u00edn","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymundo","family":"Rodr\u00edguez-Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-6629","authenticated-orcid":false,"given":"Hayde\u00e9 Salazar","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-6753","authenticated-orcid":false,"given":"Alberto","family":"Olaya-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e07740_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.heliyon.2021.e07740_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10545-005-0258-8","article-title":"Trends in haematopoietic cell transplantation for inborn errors of metabolism","volume":"29","author":"Boelens","year":"2006","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.heliyon.2021.e07740_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","article-title":"Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure","volume":"40","author":"Boelens","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.heliyon.2021.e07740_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.heliyon.2021.e07740_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pcl.2009.11.004","article-title":"Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders","volume":"57","author":"Boelens","year":"2010","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.heliyon.2021.e07740_bib6","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0002-9149(92)90908-H","article-title":"Evaluation of coronary artery disease in the Hurler syndrome by angiography","volume":"69","author":"Braunlin","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2021.e07740_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","article-title":"Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome","volume":"38","author":"Cox-Brinkman","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.heliyon.2021.e07740_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry","volume":"171","author":"D'Aco","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.heliyon.2021.e07740_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2021.e07740_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00003072-199411000-00008","article-title":"Resting Tl-201 scintigraphy in the evaluation of coronary artery disease in children with Hurler syndrome","volume":"19","author":"du Cret","year":"1994","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.heliyon.2021.e07740_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-2944(75)90064-2","article-title":"Lack of relationship bet the authorsen blood and urine levels of glycosaminoglycans and lysosomal enzymes","volume":"12","author":"Erickson","year":"1975","journal-title":"Biochem. Med."},{"key":"10.1016\/j.heliyon.2021.e07740_bib13","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical- cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e07740_bib14","first-page":"100455","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.heliyon.2021.e07740_bib15","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1542\/peds.2009-1728","article-title":"Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up","volume":"125","author":"Gabrielli","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2021.e07740_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPH.0b013e3182050945","article-title":"Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases treated with hematopoietic stem cell transplantation in a single large pediatric center: parents' perspective","volume":"33","author":"Gassas","year":"2011","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib17","first-page":"24","article-title":"Protocolo de actuaci\u00f3n en las mucopolisacaridosis","volume":"1","author":"Gonz\u00e1lez","year":"2010","journal-title":"Protoc. Diagn. Ter Pediatr."},{"key":"10.1016\/j.heliyon.2021.e07740_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.GIM.0000154299.22120.6A","article-title":"Safety an efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome","author":"Grewal","year":"2005","journal-title":"Genet. Med."},{"key":"10.1016\/j.heliyon.2021.e07740_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.12998\/wjcc.v1.i8.230","article-title":"Mongolian spots: how important are they?","volume":"1","author":"Gupta","year":"2013","journal-title":"World J. Clin. Cases."},{"key":"10.1016\/j.heliyon.2021.e07740_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.33588\/rn.43S01.2006385","article-title":"Avances en el tratamiento de las enfermedades liosomales en la infancia","volume":"43","author":"Guti\u00e9rrez","year":"2006","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e07740_bib22","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1182\/blood-2006-12-061382","article-title":"Hematopoietic stem cell\u2013targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc\/oc mice","volume":"109","author":"Johansson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2021.e07740_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e07740_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme- replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e07740_bib25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pd.457","article-title":"Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay","volume":"22","author":"Keulemans","year":"2002","journal-title":"Prenat. Diagn."},{"issue":"1-2","key":"10.1016\/j.heliyon.2021.e07740_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","article-title":"Glycosaminoglycans analysis in blood and urine of mucopolysaccharidoses by tandem mass spectrometry","volume":"125","author":"Khan","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2013.04.023","article-title":"Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings","volume":"109","author":"Laraway","year":"2013","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-5876(88)90047-X","article-title":"Resolution of obstructive sleep apnea in Hurler syndrome after bone marrow transplantation","volume":"15","author":"Malone","year":"1988","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib29","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2021.e07740_bib30","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.heliyon.2021.e07740_bib31","first-page":"19","article-title":"International consensus panel on management and treatment of mucopolysaccharidosis I, 2009. Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"An. Pediatr."},{"key":"10.1016\/j.heliyon.2021.e07740_bib32","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/bmt.2009.319","article-title":"Pre-transplant risk factors affecting outcome in Hurler syndrome","volume":"45","author":"Orchard","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.heliyon.2021.e07740_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2021.e07740_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib36","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2021.e07740_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"Hematopoietic Cell Transplantation for Inherited Metabolic Diseases: an Overview of Outcomes and Practice Guidelines","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.heliyon.2021.e07740_bib38","first-page":"104","article-title":"Clinical Trial of Laronidase in Hurler syndrome after hematopoietic cell transplantation","author":"Polgreen","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.heliyon.2021.e07740_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10545-016-0006-2","article-title":"Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience","volume":"40","author":"Rodgers","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e07740_bib40","first-page":"315","article-title":"2008 Mucopolisacaridosis tipo I con desenlace fatal durante un evento anest\u00e9sico","volume":"29","author":"Rodr\u00edguez-Herrera","year":"2008","journal-title":"Informe de un caso anatomopatol\u00f3gico Acta Pediatr Mex"},{"key":"10.1016\/j.heliyon.2021.e07740_bib41","first-page":"1","article-title":"Growth patterns in children with mucopolysaccharidosis I and II","author":"R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska","year":"2014","journal-title":"World J. Pediatr."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07740_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2017.12.007","article-title":"Glycosaminoglycan fragments as a measure of disease burden in the mucopolysaccharidosis type I mouse","volume":"123","author":"Saville","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/humu.1380060403","article-title":"Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications","volume":"6","author":"Scott","year":"1995","journal-title":"Hum. Mutat."},{"year":"1995","series-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Scriver","key":"10.1016\/j.heliyon.2021.e07740_bib44"},{"key":"10.1016\/j.heliyon.2021.e07740_bib45","first-page":"1","article-title":"Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.heliyon.2021.e07740_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A\u00a0follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib47","first-page":"17","article-title":"Prevalence and development of orthopaedic symptoms in the Dutch hurler patient population after haematopoietic stem cell transplantation","volume":"9","author":"Stoop","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.heliyon.2021.e07740_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"author":"The MPS I Registry","key":"10.1016\/j.heliyon.2021.e07740_bib49"},{"key":"10.1016\/j.heliyon.2021.e07740_bib50","first-page":"531","article-title":"Combination of enzyme replacement and hematopoitic stem cell transplantation as therapy for Hurler syndrome","author":"Tolar","year":"2007","journal-title":"Bone Marrow Transplat."},{"key":"10.1016\/j.heliyon.2021.e07740_bib51","doi-asserted-by":"crossref","first-page":"e1242","DOI":"10.1542\/peds.2009-2843","article-title":"Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation","volume":"126","author":"Valayannopoulos","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2021.e07740_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","article-title":"Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres","volume":"76","author":"Vellodi","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.heliyon.2021.e07740_bib53","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1651-2227.2005.tb02004.x","article-title":"Clinical presentation and follow-up of patients with the\u00a0attenuated phenotype of mucopolysaccharidosis type I","volume":"94","author":"Vijay","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.heliyon.2021.e07740_bib54","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbmt.2016.08.015","article-title":"Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis- A ten-year report from the China children transplant group","volume":"22","author":"Wang","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"Suppl 5","key":"10.1016\/j.heliyon.2021.e07740_bib55","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.heliyon.2021.e07740_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler\u00a0syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.heliyon.2021.e07740_bib57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1469-8749.2001.tb00249.x","article-title":"Advances in the treatment of lysosomal storage disease","volume":"43","author":"Wraith","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.heliyon.2021.e07740_bib58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"Wraith","year":"2005","journal-title":"Expet. Opin. Pharmacother."},{"key":"10.1016\/j.heliyon.2021.e07740_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-L- iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.heliyon.2021.e07740_bib60","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2021.e07740_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2008.07.004","article-title":"Use of enzyme\u00a0replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients","volume":"154","author":"Wynn","year":"2009","journal-title":"J.\u00a0Pediatr."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021018430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021018430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T04:42:11Z","timestamp":1767760931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021018430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2405844021018430"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07740","relation":{},"ISSN":["2405-8440"],"issn-type":[{"type":"print","value":"2405-8440"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e07740"}}